Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-06-16 @ 7:03 PM
Study NCT ID:
NCT03056833
Status:
COMPLETED
Last Update Posted:
2022-09-07
First Post:
2017-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Sponsor:
Ronald Buckanovich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
18-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None